| __timestamp | Amgen Inc. | Sarepta Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 20063000000 | 9757000 |
| Thursday, January 1, 2015 | 21662000000 | 1253000 |
| Friday, January 1, 2016 | 22991000000 | 5421000 |
| Sunday, January 1, 2017 | 22849000000 | 154584000 |
| Monday, January 1, 2018 | 23747000000 | 301034000 |
| Tuesday, January 1, 2019 | 23362000000 | 380833000 |
| Wednesday, January 1, 2020 | 25424000000 | 540099000 |
| Friday, January 1, 2021 | 25979000000 | 701887000 |
| Saturday, January 1, 2022 | 26323000000 | 933013000 |
| Sunday, January 1, 2023 | 28190000000 | 1243336000 |
| Monday, January 1, 2024 | 33424000000 |
Unlocking the unknown
In the dynamic world of biotechnology, revenue growth is a key indicator of a company's success and market position. Over the past decade, Amgen Inc. and Sarepta Therapeutics, Inc. have showcased contrasting trajectories in their annual revenues. From 2014 to 2023, Amgen's revenue surged by approximately 40%, reaching a peak of $28.19 billion in 2023. This growth underscores Amgen's robust market presence and strategic advancements in the biotech sector.
Conversely, Sarepta Therapeutics, Inc. has experienced a remarkable revenue growth rate, albeit from a smaller base. Starting with a modest $9.76 million in 2014, Sarepta's revenue skyrocketed to $1.24 billion by 2023, marking an impressive increase of over 12,000%. This exponential growth highlights Sarepta's innovative breakthroughs and expanding influence in the field of genetic medicine.
These figures not only reflect the companies' financial health but also their strategic positioning in the competitive biotech landscape.
Novo Nordisk A/S or Sarepta Therapeutics, Inc.: Who Leads in Yearly Revenue?
Novartis AG or Sarepta Therapeutics, Inc.: Who Leads in Yearly Revenue?
Who Generates More Revenue? Amgen Inc. or Zoetis Inc.
Who Generates More Revenue? Amgen Inc. or argenx SE
Amgen Inc. or Incyte Corporation: Who Leads in Yearly Revenue?
Cost Insights: Breaking Down Amgen Inc. and Sarepta Therapeutics, Inc.'s Expenses
Who Optimizes SG&A Costs Better? Amgen Inc. or Sarepta Therapeutics, Inc.
Who Generates More Revenue? GSK plc or Sarepta Therapeutics, Inc.
Alnylam Pharmaceuticals, Inc. vs Sarepta Therapeutics, Inc.: Annual Revenue Growth Compared
Comparing Revenue Performance: Sarepta Therapeutics, Inc. or Ascendis Pharma A/S?
Who Generates More Revenue? Sarepta Therapeutics, Inc. or Merus N.V.
Revenue Insights: Sarepta Therapeutics, Inc. and MiMedx Group, Inc. Performance Compared